source
- Novo Nordisk leads early in oral obesity market, but analysts doubt lasting advantageNovo Nordisk's oral formulation of Wegovy generated DKK 3.22 billion (about $496 million) in revenue in the second quarter of 2026, far outpacing Eli Lilly's newly approved oral weight‑loss pill Fo…
- Trump nominates White House aide Heidi Overton as FDA commissionerPresident Donald Trump is reported to be selecting Deputy Director of the White House Domestic Policy Council Heidi Overton, a physician, to be the next FDA commissioner, pending Senate confirmatio…